Lifecore Biomedical Inc (LFCR)

$7.33 +0.11 (1.52%)
Market Cap 270.50M
Revenue (ttm) 128.87M
Net Income (ttm) -38.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -30.05%
Debt to Equity Ratio 4.36
Volume 104,700
Avg Vol 148,238
Day's Range N/A - N/A
Shares Out 37.47M
Stochastic %K 76%
Beta 0.59
Analysts Sell
Price Target $9.25

Company Profile

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacture of hyaluronate acid in bulk form; and formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. It also provides product development services include analytical method development and validation, formulation development...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 952 368 4300
Address:
3515 Lyman Boulevard, Chaska, United States
11thestate
11thestate Feb. 18 at 3:22 PM
$LFCR has agreed to settle with investors over claims that weak internal controls led to inaccurate financial statements and overstated prospects. Who’s eligible? Anyone who purchased $LFCR shares between October 7, 2020 and March 19, 2024. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.20 — but normally only about 25% of eligible investors file claims. If that trend holds, the effective payout could rise to approximately $0.80 per share. Can I still file? Yes — the settlement terms have been submitted to the court for approval and claims are expected to be accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 16 at 7:49 PM
$LFCR Share Price: $7.08 Contract Selected: Sep 18, 2026 $7.5 Calls Buy Zone: $0.30 – $0.37 Target Zone: $0.54 – $0.66 Potential Upside: 71% ROI Time to Expiration: 213 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ThanhSurratt914
ThanhSurratt914 Feb. 11 at 2:36 PM
$LFCR Lifecore Biomedical; CDMO and CRO services; restructuring and debt overhang; needs to demonstrate operational stability and organic growth.
0 · Reply
11thestate
11thestate Feb. 6 at 12:51 PM
With everything going on around $LFCR lately — this is the info you don’t want to miss: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 5 at 1:10 AM
$LFCR Current Stock Price: $7.91 Contracts to trade: $7.5 LFCR Feb 20 2026 Call Entry: $0.35 Exit: $0.45 ROI: 27% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
11thestate
11thestate Jan. 16 at 2:42 PM
$LFCR is now accepting claims for a settlement it is paying to investors over claims that it misled investors about financial controls and business prospects. If you bought $LFCR between October 7, 2020 and March 19, 2024, you still can file for payment here: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
BearTamerTrading
BearTamerTrading Jan. 11 at 11:57 PM
On Watch for JPM Week: Part 2 $MLAB – Mesa Labs – will present on Jan 14, 2026. $AAPG – Ascentage Pharma Group International – announced presentation. $LFCR – Lifecore Biomedical – participating (1-on-1s and meetings).
0 · Reply
11thestate
11thestate Jan. 6 at 2:41 PM
Don't forget that there is also an important settlement to watch for $LFCR We have every detail, including how investors can get paid: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
PrecisionChartist
PrecisionChartist Dec. 27 at 6:14 AM
$LFCR Sentiment increasingly tracks operational truth rather than guidance tone. Governance alignment can reduce perceived uncertainty. Execution consistency is the fastest path to confidence rebuilding. Execution quality becomes the defining catalyst from here.
0 · Reply
11thestate
11thestate Dec. 23 at 2:58 PM
$LFCR investors, if you follow us, you already know about it. This info hits different after the news. Check it out: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
Latest News on LFCR
Lifecore Biomedical to Participate at DCAT Week 2026

Feb 17, 2026, 7:05 AM EST - 9 days ago

Lifecore Biomedical to Participate at DCAT Week 2026

HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Jan 29, 2026, 5:09 PM EST - 27 days ago

HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jan 16, 2026, 4:45 PM EST - 5 weeks ago

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Jan 15, 2026, 10:39 AM EST - 5 weeks ago

Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Lifecore Biomedical: The Turnaround Is Just Getting Started

Jan 1, 2026, 8:50 AM EST - 2 months ago

Lifecore Biomedical: The Turnaround Is Just Getting Started

Lifecore Biomedical to be Added to Nasdaq Biotech Index

Dec 18, 2025, 7:00 AM EST - 2 months ago

Lifecore Biomedical to be Added to Nasdaq Biotech Index

Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer

Dec 17, 2025, 7:00 AM EST - 2 months ago

Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer

Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference

Dec 16, 2025, 7:00 AM EST - 2 months ago

Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference

Lifecore Biomedical to Participate in Upcoming Investor Conferences

Nov 11, 2025, 4:05 PM EST - 3 months ago

Lifecore Biomedical to Participate in Upcoming Investor Conferences

Lifecore Biomedical, Inc. (LFCR) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 8:56 PM EST - 3 months ago

Lifecore Biomedical, Inc. (LFCR) Q3 2025 Earnings Call Transcript

Lifecore Biomedical Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate Update

Nov 6, 2025, 4:05 PM EST - 3 months ago

Lifecore Biomedical Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate Update

Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025

Oct 30, 2025, 4:05 PM EDT - 4 months ago

Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025

Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

Oct 29, 2025, 7:00 AM EDT - 4 months ago

Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

Oct 28, 2025, 7:00 AM EDT - 4 months ago

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

Oct 13, 2025, 7:00 AM EDT - 4 months ago

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Sep 23, 2025, 4:30 PM EDT - 5 months ago

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Lifecore Biomedical, Inc. (LFCR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 7:07 PM EDT - 6 months ago

Lifecore Biomedical, Inc. (LFCR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference

Sep 4, 2025, 4:05 PM EDT - 6 months ago

Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference

Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript

Aug 8, 2025, 9:16 AM EDT - 7 months ago

Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript

Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update

Aug 7, 2025, 4:05 PM EDT - 7 months ago

Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update

Laughing Water Capital's Top 5 Positions For Q2 2025

Aug 7, 2025, 4:45 AM EDT - 7 months ago

Laughing Water Capital's Top 5 Positions For Q2 2025

Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025

Jul 31, 2025, 4:05 PM EDT - 7 months ago

Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025

Stock Picks From Seeking Alpha's June 2025 New Analysts

Jul 8, 2025, 9:00 AM EDT - 8 months ago

Stock Picks From Seeking Alpha's June 2025 New Analysts

AENT AHCO APP ASGN ASML ASTS CRCL

Lifecore Biomedical: Inflecting Financials Over Next 3 Years

Jun 18, 2025, 3:27 AM EDT - 9 months ago

Lifecore Biomedical: Inflecting Financials Over Next 3 Years

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect

Jun 17, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect

Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer

Jun 17, 2025, 7:00 AM EDT - 9 months ago

Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jun 15, 2025, 10:00 AM EDT - 9 months ago

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation

Jun 12, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation

Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale

Jun 12, 2025, 7:00 AM EDT - 9 months ago

Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation

Jun 10, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out

Jun 8, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation

Jun 5, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 3, 2025, 10:00 AM EDT - 9 months ago

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation

Jun 1, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 29, 2025, 10:05 AM EDT - 9 months ago

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect

May 27, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect

Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer

May 27, 2025, 7:00 AM EDT - 9 months ago

Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation

May 25, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation

May 22, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation

Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings

May 19, 2025, 9:35 AM EDT - 10 months ago

Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings

BUR CLBT KKR PAR

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Reach Out

May 11, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Reach Out

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out

May 8, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect

Apr 29, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect

Laughing Water Capital Top 5 Investments (Q1 2025)

Apr 24, 2025, 11:30 AM EDT - 11 months ago

Laughing Water Capital Top 5 Investments (Q1 2025)

ARR NN PAR PLYA

Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference

Apr 22, 2025, 7:00 AM EDT - 11 months ago

Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference

Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer

Apr 14, 2025, 7:00 AM EDT - 11 months ago

Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer

Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update

Apr 3, 2025, 4:05 PM EDT - 11 months ago

Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update

Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025

Mar 27, 2025, 4:05 PM EDT - 11 months ago

Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025

11thestate
11thestate Feb. 18 at 3:22 PM
$LFCR has agreed to settle with investors over claims that weak internal controls led to inaccurate financial statements and overstated prospects. Who’s eligible? Anyone who purchased $LFCR shares between October 7, 2020 and March 19, 2024. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.20 — but normally only about 25% of eligible investors file claims. If that trend holds, the effective payout could rise to approximately $0.80 per share. Can I still file? Yes — the settlement terms have been submitted to the court for approval and claims are expected to be accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 16 at 7:49 PM
$LFCR Share Price: $7.08 Contract Selected: Sep 18, 2026 $7.5 Calls Buy Zone: $0.30 – $0.37 Target Zone: $0.54 – $0.66 Potential Upside: 71% ROI Time to Expiration: 213 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ThanhSurratt914
ThanhSurratt914 Feb. 11 at 2:36 PM
$LFCR Lifecore Biomedical; CDMO and CRO services; restructuring and debt overhang; needs to demonstrate operational stability and organic growth.
0 · Reply
11thestate
11thestate Feb. 6 at 12:51 PM
With everything going on around $LFCR lately — this is the info you don’t want to miss: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 5 at 1:10 AM
$LFCR Current Stock Price: $7.91 Contracts to trade: $7.5 LFCR Feb 20 2026 Call Entry: $0.35 Exit: $0.45 ROI: 27% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
11thestate
11thestate Jan. 16 at 2:42 PM
$LFCR is now accepting claims for a settlement it is paying to investors over claims that it misled investors about financial controls and business prospects. If you bought $LFCR between October 7, 2020 and March 19, 2024, you still can file for payment here: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
BearTamerTrading
BearTamerTrading Jan. 11 at 11:57 PM
On Watch for JPM Week: Part 2 $MLAB – Mesa Labs – will present on Jan 14, 2026. $AAPG – Ascentage Pharma Group International – announced presentation. $LFCR – Lifecore Biomedical – participating (1-on-1s and meetings).
0 · Reply
11thestate
11thestate Jan. 6 at 2:41 PM
Don't forget that there is also an important settlement to watch for $LFCR We have every detail, including how investors can get paid: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
PrecisionChartist
PrecisionChartist Dec. 27 at 6:14 AM
$LFCR Sentiment increasingly tracks operational truth rather than guidance tone. Governance alignment can reduce perceived uncertainty. Execution consistency is the fastest path to confidence rebuilding. Execution quality becomes the defining catalyst from here.
0 · Reply
11thestate
11thestate Dec. 23 at 2:58 PM
$LFCR investors, if you follow us, you already know about it. This info hits different after the news. Check it out: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
BearTamerTrading
BearTamerTrading Dec. 18 at 4:07 PM
📈 Market Alerts — Bear Tamer Trading Part 2 of 2 - 12/17/22 🔥 $AMCI — AMC Robotics Volatile mover during the session — reminder why risk management is always priority. 🔥 $LFCR — Lifecore Biomedical Strong intraday action with buyers stepping in and price holding key levels. 🔥 $PCSA — Processa Pharmaceuticals High-risk, high-reward biotech with sharp moves that required discipline. 🔥 $TGL — Treasure Global Choppy but tradable action during market hours, stayed active into the close. 🔥 $UDMY — Udemy Held steady throughout the session, remained on radar as a potential continuation setup. Congrats again to everyone who stayed locked in during Market Alerts 💰👏 Proof of live coverage here ⬇️ 🔗 https://www.youtube.com/live/AfPLYIui4Lw?si=xQ950lEw771yVB7A
2 · Reply
DARKP00L
DARKP00L Dec. 18 at 12:10 PM
$LFCR 07:03 on Dec. 18 2025 Lifecore Biomedical To Join Nasdaq Biotechnology Index Effective Before Market Open December 22, 2025 #tradeideas
0 · Reply
DARKP00L
DARKP00L Dec. 17 at 5:37 PM
$LFCR 12:12 on Dec. 17 2025 Lifecore Biomedical shares are trading higher after the company announced that it has signed a CDMO master services agreement with a global pharmaceutical customer. #tradeideas
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 16 at 1:22 PM
$LFCR Share Price: $7.89 Contract Selected: Jun 18, 2026 $10 Calls Buy Zone: $0.42 – $0.53 Target Zone: $0.74 – $0.91 Potential Upside: 65% ROI Time to Expiration: 183 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
11thestate
11thestate Dec. 11 at 3:24 PM
$LFCR has reached a settlement with investors over claims that it issued inaccurate financial statements due to weak internal controls and overstated its financial position. Who’s eligible? Anyone who purchased $LFCR shares between October 7, 2020 and March 19, 2024. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? Payout per share not determined yet. Can I still file? Yes — claims are currently being accepted under a tentative settlement. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
JarvisFlow
JarvisFlow Dec. 8 at 2:37 PM
Stephens & Co. has updated their rating for Lifecore Biomedical ( $LFCR ) to Equal-Weight with a price target of 6.
0 · Reply
11thestate
11thestate Nov. 26 at 3:34 PM
Don't forget that there is also an important settlement to watch for $LFCR. We have every detail, including how investors can get paid. #LFCR #LifecoreBiomedical https://11th.com/cases/lifecore-investor-settlement
0 · Reply
WeFindBitcoin
WeFindBitcoin Nov. 25 at 6:27 PM
$LFCR super low flat, this is my safe harbor in the storm. holding this i'm not worry about anything.
0 · Reply
Doozio
Doozio Nov. 23 at 5:02 PM
$LFCR chop chop huckleberries rotation and all that $JAZZ 🐒🍌🧠⏰♾️
0 · Reply